Review



amplifier (hq-hapentated tyramide)  (OptiView Technologies)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    OptiView Technologies amplifier (hq-hapentated tyramide)
    Amplifier (Hq Hapentated Tyramide), supplied by OptiView Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/amplifier+(hq-hapentated+tyramide)/amplifier++hq+hapentated+tyramide+/pm28147239-37-7-7
    Average 90 stars, based on 1 article reviews
    amplifier (hq-hapentated tyramide) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Amplification:

    Article Title: A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib.
    Article Snippet: The amplification kit involves addition of the OptiView Amplifier (HQ-hapentated tyramide), OptiView Amplification H2O2 (the substrate), and the OptiView Amplification Multimer (a anti-HQ HRP conjugated monoclonal antibody) which builds on the scaffolding generated from the OptiView DAB IHC Detection Kit. (21) During assay development, extensive feasibility testing was conducted on 139 NSCLC specimens (Feasibility Case Set) representing a range of ALK positive and ALK negative samples (79 ALK FISH+ and 60 ALK FISH) to optimize sensitivity and specificity of the assay enabling detection of low ALK expressors with high concordance to FISH.

    Scaffolding:

    Article Title: A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib.
    Article Snippet: The amplification kit involves addition of the OptiView Amplifier (HQ-hapentated tyramide), OptiView Amplification H2O2 (the substrate), and the OptiView Amplification Multimer (a anti-HQ HRP conjugated monoclonal antibody) which builds on the scaffolding generated from the OptiView DAB IHC Detection Kit. (21) During assay development, extensive feasibility testing was conducted on 139 NSCLC specimens (Feasibility Case Set) representing a range of ALK positive and ALK negative samples (79 ALK FISH+ and 60 ALK FISH) to optimize sensitivity and specificity of the assay enabling detection of low ALK expressors with high concordance to FISH.

    Generated:

    Article Title: A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib.
    Article Snippet: The amplification kit involves addition of the OptiView Amplifier (HQ-hapentated tyramide), OptiView Amplification H2O2 (the substrate), and the OptiView Amplification Multimer (a anti-HQ HRP conjugated monoclonal antibody) which builds on the scaffolding generated from the OptiView DAB IHC Detection Kit. (21) During assay development, extensive feasibility testing was conducted on 139 NSCLC specimens (Feasibility Case Set) representing a range of ALK positive and ALK negative samples (79 ALK FISH+ and 60 ALK FISH) to optimize sensitivity and specificity of the assay enabling detection of low ALK expressors with high concordance to FISH.

    Immunohistochemistry:

    Article Title: A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib.
    Article Snippet: The amplification kit involves addition of the OptiView Amplifier (HQ-hapentated tyramide), OptiView Amplification H2O2 (the substrate), and the OptiView Amplification Multimer (a anti-HQ HRP conjugated monoclonal antibody) which builds on the scaffolding generated from the OptiView DAB IHC Detection Kit. (21) During assay development, extensive feasibility testing was conducted on 139 NSCLC specimens (Feasibility Case Set) representing a range of ALK positive and ALK negative samples (79 ALK FISH+ and 60 ALK FISH) to optimize sensitivity and specificity of the assay enabling detection of low ALK expressors with high concordance to FISH.

    Fluorescence In Situ Hybridization:

    Article Title: A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with Crizotinib.
    Article Snippet: The amplification kit involves addition of the OptiView Amplifier (HQ-hapentated tyramide), OptiView Amplification H2O2 (the substrate), and the OptiView Amplification Multimer (a anti-HQ HRP conjugated monoclonal antibody) which builds on the scaffolding generated from the OptiView DAB IHC Detection Kit. (21) During assay development, extensive feasibility testing was conducted on 139 NSCLC specimens (Feasibility Case Set) representing a range of ALK positive and ALK negative samples (79 ALK FISH+ and 60 ALK FISH) to optimize sensitivity and specificity of the assay enabling detection of low ALK expressors with high concordance to FISH.



    Similar Products

    amplifier (hq-hapentated tyramide)  (OptiView Technologies)
    90
    OptiView Technologies amplifier (hq-hapentated tyramide)
    Amplifier (Hq Hapentated Tyramide), supplied by OptiView Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/amplifier+(hq-hapentated+tyramide)/amplifier++hq+hapentated+tyramide+/pm28147239-37-7-7
    Average 90 stars, based on 1 article reviews
    amplifier (hq-hapentated tyramide) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results